SCHEMBL5312856

SCHEMBL5312856

CC(=O)C(=O)OOP(=O)(O)O

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.32
BLM P54132 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CA4 P22748 1/20 0.31
TSHR P16473 1/20 0.30
THPO P40225 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL908616 0.80 ALDH1A1 (0.44) TDP1TSHR
SCHEMBL11518153 0.78
SCHEMBL1548799 0.78
SCHEMBL11526816 0.77
SCHEMBL26655448 0.76 ALDH1A1 (0.33) FDPSBLMTDP1CA4TSHR
Ethylene Glycol SCHEMBL2336848 0.73 ALDH1A1 (0.38) TSHR
SCHEMBL15282816 0.73 TSHR (0.46) BLMTDP1CA4TSHRTHPO
SCHEMBL249493 0.72 CA4 (0.46) FDPSBLMTDP1CA4TSHR
SCHEMBL20481779 0.70 CA4 (0.43) FDPSBLMTDP1CA4TSHR
SCHEMBL27717428 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112566633-A Method of enhancing glucose levels in the central nervous system 民族医学研究所 2021-03-26 CN disclosed
WO-2007002088-A2 PSAT1S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE EXELIXIS, INC. (US) 2007-01-04 WO disclosed